Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followup

Objective To report a single‐center experience with the use of tumor necrosis factor (TNF) inhibitors in patients with Takayasu arteritis (TA). Methods We retrospectively studied a cohort of patients with refractory TA evaluated at our institution and treated with TNF inhibitors. American College of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis care & research (2010) 2012-07, Vol.64 (7), p.1079-1083
Hauptverfasser:	Schmidt, Jean, Kermani, Tanaz A., Bacani, A. Kirstin, Crowson, Cynthia S., Matteson, Eric L., Warrington, Kenneth J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adult Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Drug Therapy, Combination Etanercept Female Follow-Up Studies Humans Immunoglobulin G - adverse effects Immunoglobulin G - therapeutic use Infliximab Longitudinal Studies Male Prednisone - therapeutic use Receptors, Tumor Necrosis Factor - therapeutic use Recurrence Remission Induction Retrospective Studies Takayasu Arteritis - drug therapy Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!